Live Quote · NASDAQRLAYHealthcare· Biotechnology

Relay Therapeutics, Inc.

$15.91
MKT CAP $3.52B
50%
Bullish
TickerSpark Score
63/100
▌ Mixed
33
Valuation
40
Profitability
100
Growth
80
Health

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RLAY research report →

Analyst Price Target
$29.00+82.3% vs. today

Range $26 – $31

Analyst RatingBuy
16 Buy0 Hold0 Sell

Price Chart

+150.95% · this period
$20.75$13.54$6.34Nov 19May 22Nov 19